Nuzenio

Vidac Pharma Holding

Vidac Pharma Holding news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Vidac Pharma Holdings Plc Announces Commencement of Trading on Xetra - The National Law ReviewThe National Law Review · Sat, 08 Aug 2026 21:50:03 GMTCaution with BioNTech! Novo Nordisk Accelerates! Buying Opportunity in Vidac Pharma Stock? - news.financialnews.financial · Fri, 07 Aug 2026 05:20:00 GMT"Buy the Dip" in the Life Sciences Supercycle: Gerresheimer, Vidac Pharma, Novo Nordisk, and Pfizer as Top Performers of the Future - StockhouseStockhouse · Tue, 04 Aug 2026 07:24:52 GMTVidac Pharma Holding PLC Approved for Inclusion on Düsseldorf Stock Exchange Open and Primary Markets - The National Law ReviewThe National Law Review · Tue, 04 Aug 2026 06:07:25 GMTVidac Pharma Reports First Patient Dosed in Phase 2b Study of VDA-1102 for High-Risk Actinic Keratosis - The National Law ReviewThe National Law Review · Tue, 04 Aug 2026 01:33:11 GMTEnterprise value to revenue forward of Vidac Pharma Holding Plc – XETR:T9G - TradingViewTradingView · Sat, 01 Aug 2026 04:22:43 GMTMitteilung über Eigengeschäfte von Führungskräften gemäß Artikel 19 MAR - TradingViewTradingView · Tue, 28 Jul 2026 17:01:14 GMT

Timeline

Sat, 08 Aug 2026 21:50:03 GMTVidac Pharma Holdings Plc Announces Commencement of Trading on Xetra - The National Law Review
Fri, 07 Aug 2026 05:20:00 GMTCaution with BioNTech! Novo Nordisk Accelerates! Buying Opportunity in Vidac Pharma Stock? - news.financial
Tue, 04 Aug 2026 07:24:52 GMT"Buy the Dip" in the Life Sciences Supercycle: Gerresheimer, Vidac Pharma, Novo Nordisk, and Pfizer as Top Performers of the Future - Stockhouse
Tue, 04 Aug 2026 06:07:25 GMTVidac Pharma Holding PLC Approved for Inclusion on Düsseldorf Stock Exchange Open and Primary Markets - The National Law Review
Tue, 04 Aug 2026 01:33:11 GMTVidac Pharma Reports First Patient Dosed in Phase 2b Study of VDA-1102 for High-Risk Actinic Keratosis - The National Law Review
Sat, 01 Aug 2026 04:22:43 GMTEnterprise value to revenue forward of Vidac Pharma Holding Plc – XETR:T9G - TradingView

Related explainers

PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Vidac Pharma Holding.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.